High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach

Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Shah, Nisha B., Mitchell, Rhonita E., Proctor, Stephanie Terry, Choi, Leena, DeClercq, Joshua, Jolly, Jacob A., Hemnes, Anna R., Zuckerman, Autumn D.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553732/
https://ncbi.nlm.nih.gov/pubmed/31170217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0217798
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki